29 related articles for article (PubMed ID: 38531383)
1. The Clinical Profile of Patients with Psoriasis in Korea: A Nationwide Cross-Sectional Study (EPI-PSODE).
Song HJ; Park CJ; Kim TY; Choe YB; Lee SJ; Kim NI; Cho JW; Jeon JH; Jang MS; Youn JI; Kim MH; Park J; Kim KH; Kim BS; Youn SW; Lee JH; Lee MG; Ahn SK; Won YH; Yun SK; Shin BS; Seo SJ; Lee JY; Kim KJ; Ro YS; Kim Y; Yu DY; Choi JH
Ann Dermatol; 2017 Aug; 29(4):462-470. PubMed ID: 28761295
[TBL] [Abstract][Full Text] [Related]
2. Measurement assessment of Minimal Disease Activity in psoriasis in Spain: a national cross-sectional study.
Carretero Hernández G; Ara Martín M; Armesto Alonso S; Belinchón Romero I; Eiris Salvado N; Ferrán Farrés M; Galache Osuna C; García Bustínduy M; de Araníbar JGL; Juliá Manresa M; Llamas Velasco M; López Ferrer A; Roncero Riesco M; Ruiz Genao D; Ruíz-Villaverde R; Salgado Boquete L; Soria Martínez C; Vilarrasa E; Descalzo MA;
Actas Dermosifiliogr; 2024 Jun; ():. PubMed ID: 38876209
[TBL] [Abstract][Full Text] [Related]
3. Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment.
Thomas SE; Seyger MMB; Mangnus JE; Otero ME; Gostynski AH; Njoo MD; Ossenkoppele PM; Haeck IM; Hendricksen-Roelofzen JHJ; Körver JEM; Dodemont SRP; Tupker RA; Berends MAM; Weppner-Parren LMJT; Keijsers RRMC; Oostveen AM; Peters B; Mommers R; van Doorn MBA; Tjioe M; Veldkamp WR; Kuijpers ALA; Kleinpenning MM; de Jong EMGJ; van den Reek JMPA
Am J Clin Dermatol; 2024 May; ():. PubMed ID: 38802618
[No Abstract] [Full Text] [Related]
4. The impact of PASI 75 and PASI 90 on quality of life in moderate to severe psoriasis patients.
Abrouk M; Nakamura M; Zhu TH; Farahnik B; Koo J; Bhutani T
J Dermatolog Treat; 2017 Sep; 28(6):488-491. PubMed ID: 28042711
[TBL] [Abstract][Full Text] [Related]
5. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011535. PubMed ID: 33871055
[TBL] [Abstract][Full Text] [Related]
6. Long-term, durable, absolute Psoriasis Area and Severity Index and health-related quality of life improvements with risankizumab treatment: a post hoc integrated analysis of patients with moderate-to-severe plaque psoriasis.
Gooderham M; Pinter A; Ferris LK; Warren RB; Zhan T; Zeng J; Soliman AM; Kaufmann C; Kaplan B; Photowala H; Strober B
J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):855-865. PubMed ID: 35174556
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysis.
Stull DE; Griffiths CEM; Gilloteau I; Zhao Y; Guana A; Finlay AY; Sherif B; Houghton K; Puig L
Br J Dermatol; 2018 Jun; 178(6):1297-1307. PubMed ID: 29355896
[TBL] [Abstract][Full Text] [Related]
8. Short-term effectiveness and potential factors of ustekinumab based on real-world data in Chinese psoriasis patients.
Li X; Xie X; Li J; Hu J; Hu K; Tan M; Yang J; Deng S; Liu Y; Zhang M; Kuang Y; Chen J; Liao L; Zhu W
J Dermatolog Treat; 2024 Dec; 35(1):2321188. PubMed ID: 38531383
[TBL] [Abstract][Full Text] [Related]
9. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
[TBL] [Abstract][Full Text] [Related]
10. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
Cochrane Database Syst Rev; 2022 May; 5(5):CD011535. PubMed ID: 35603936
[TBL] [Abstract][Full Text] [Related]
11. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Guelimi R; Garcia-Doval I; Hua C; Hughes C; Naldi L; Kinberger M; Afach S; Le Cleach L
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD011535. PubMed ID: 37436070
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
